Novanta (NOVT) Scheduled to Post Quarterly Earnings on Tuesday

Novanta (NASDAQ:NOVT) is set to issue its quarterly earnings data before the market opens on Tuesday, August 6th. Analysts expect the company to announce earnings of $0.69 per share for the quarter. Novanta has set its Q2 guidance at $0.68 to $0.74 EPS.Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Novanta (NASDAQ:NOVT) last announced its quarterly earnings results on Tuesday, May 7th. The technology company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.57 by $0.17. The firm had revenue of $230.92 million for the quarter, compared to analyst estimates of $227.85 million. Novanta had a net margin of 7.76% and a return on equity of 16.58%. Novanta’s revenue for the quarter was up 5.4% compared to the same quarter last year. During the same period last year, the business earned $0.74 EPS. On average, analysts expect Novanta to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Novanta Stock Down 4.5 %

Shares of NASDAQ:NOVT opened at $162.69 on Monday. The company has a market cap of $5.84 billion, a price-to-earnings ratio of 84.30 and a beta of 1.31. The firm’s 50-day simple moving average is $167.27 and its 200-day simple moving average is $165.25. The company has a quick ratio of 1.77, a current ratio of 2.83 and a debt-to-equity ratio of 0.75. Novanta has a fifty-two week low of $111.20 and a fifty-two week high of $187.12.

Insider Buying and Selling

In other Novanta news, CFO Robert Buckley sold 1,830 shares of the firm’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $161.09, for a total transaction of $294,794.70. Following the completion of the transaction, the chief financial officer now owns 120,419 shares of the company’s stock, valued at $19,398,296.71. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In other news, CFO Robert Buckley sold 1,830 shares of the firm’s stock in a transaction on Monday, July 1st. The stock was sold at an average price of $161.09, for a total transaction of $294,794.70. Following the sale, the chief financial officer now owns 120,419 shares in the company, valued at $19,398,296.71. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Matthijs Glastra sold 1,086 shares of Novanta stock in a transaction on Monday, July 1st. The shares were sold at an average price of $160.84, for a total value of $174,672.24. Following the completion of the transaction, the chief executive officer now owns 23,486 shares in the company, valued at approximately $3,777,488.24. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 7,576 shares of company stock valued at $1,269,244. Corporate insiders own 1.20% of the company’s stock.

About Novanta

Novanta Inc, together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation.